Invention Grant
- Patent Title: Tritoqualine for use in the treatment of cystic fibrosis
- Patent Title (中): 用于治疗囊性纤维化的特氟噻嗪
-
Application No.: US14397743Application Date: 2013-04-19
-
Publication No.: US09301955B2Publication Date: 2016-04-05
- Inventor: Dominique Costantini
- Applicant: ORPHAN SYNERGY EUROPE-PHARMA
- Applicant Address: FR Paris
- Assignee: ORPHAN SYNERGY EUROPE-PHARMA
- Current Assignee: ORPHAN SYNERGY EUROPE-PHARMA
- Current Assignee Address: FR Paris
- Agency: Nixon & Vanderhye P.C.
- Priority: EP12305487 20120430
- International Application: PCT/EP2013/058158 WO 20130419
- International Announcement: WO2013/164204 WO 20131107
- Main IPC: A61K31/4741
- IPC: A61K31/4741
Abstract:
This invention relates to tritoqualine for use in the treatment of cystic fibrosis or any one of its complications. The invention also relates to the method for the treatment of cystic fibrosis or any one of its complications by administering tritoqualine. The invention can be used to improve the condition of individuals with cystic fibrosis.
Public/Granted literature
- US20150133487A1 TRITOQUALINE FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS Public/Granted day:2015-05-14
Information query
IPC分类:
